Combination Product: mavrilimumab ( DrugBank: Mavrilimumab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
41	巨細胞性動脈炎	1

41. 巨細胞性動脈炎

臨床試験数 : 131 / 薬物数 : 139 - (DrugBank : 36) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 125

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03827018 (ClinicalTrials.gov)	September 20, 2018	25/1/2019	KPL-301 for Subjects With Giant Cell Arteritis	A Phase 2, Randomized, Double-blind Placebo-controlled Study to Test the Efficacy and Safety of KPL- ...	Giant Cell Arteritis	Combination Product: mavrilimumab;Combination Product: placebo;Drug: prednisone	Kiniksa Pharmaceuticals, Ltd.	NULL	Completed	50 Years	85 Years	All	70	Phase 2	United States;Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland ...

First Previous1Next Last